Endocrine Disruption Screening Market Size, Segments, and Trends by 2028
Endocrine Disruption Screening Market: Strategic Insights
Endocrine Disruption Screening Market
-
CAGR (2021 - 2028)2.8% -
Market Size 2021
US$ 126.53 Million -
Market Size 2028
US$ 153.30 Million
Market Dynamics
GROWTH DRIVERS
- Growing concern for chemical safety.
- Stringent regulatory testing requirements.
- Rise in chronic endocrine disorders.
FUTURE TRENDS
- AI-driven predictive screening models.
- Demand for cost-effective testing methods.
- Integration of in-silico screening tools.
OPPORTUNITIES
- Growth in bioassay-based screenings.
- Development of high-throughput screening tools.
- Increased focus on environmental screening.
Key Players
- CREATIVE BIOARRAY
- XENOMETRIX AG
- CHARLES RIVER
- EUROFINS SCIENTIFIC
- SMITHERS
- SGS SA
- JRF GLOBAL
- M RIEUX NUTRISCIENCES
- ALPHA ANALYTICAL
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Assay Type - In-Vitro and In-Vivo
Application - Natural Materials and Synthetic Materials
Sources of Waste - Incineration and Landfill
- Agricultural Runoff
- Industrial and Municipal Effluents
- Pulp Mill Effluents
- Consumer Products
Method - Estrogen Receptor Transactivation
- Androgen Receptor Transactivation
- Androgen Receptor Modulation
- Estrogen Receptor-Alpha Binding
- Estrogen Receptor-Beta Binding
- Androgen Receptor Binding
- Steroidogenesis
- Aromatase Assay
Get Free Sample For